PLXbenzinga

Protalix BioTherapeutics FY 2024 GAAP EPS $0.04 Beats $0.01 Estimate, Sales $53.40M Miss $53.94M Estimate

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 17, 2025 by benzinga

    Protalix BioTherapeutics FY 2024 GAAP EPS $0.04 Beats $0.01 Estimate, Sales $53.40M Miss $53.94M Estimate | PLX Stock News | Candlesense